Vanda Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vanda Pharmaceuticals Inc
TickerVNDA
CIK #0001347178
CUSIP921659108
SectorLife Sciences - Pharmaceutical Preparations
Address9605 Medical Center Drive Suite 300, Rockville, MD 20850
Source [EDGAR]
CIK Filing 2011 - 2025
[0001347178] 10-K
[0001347178] 10-Q
[0001347178] 3
[0001347178] 4
[0001347178] 5
[0001347178] 8-K
[0001347178] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Vanda Pharmaceuticals Inc [2025-07-01] 0.0
BlackRock Portfolio Management LLC Vanda Pharmaceuticals Inc [2025-04-15] 0.0
Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc [2023-02-10] 5.0
State Street Corp Vanda Pharmaceuticals Inc [2021-02-11] 5.86
BlackRock Inc Vanda Pharmaceuticals Inc [2021-01-25] 17.9
Renaissance Technologies LLC Vanda Pharmaceuticals Inc [2020-02-12] 6.47
Armistice Capital LLC Vanda Pharmaceuticals Inc [2019-06-24] 6.2
Consonance Capital Management LP Vanda Pharmaceuticals Inc [2019-02-14] 8.53
Macquarie Group Ltd Vanda Pharmaceuticals Inc [2018-02-14] 5.02
Vanguard Group Inc Vanda Pharmaceuticals Inc [2018-02-09] 6.3
Armistice Capital LLC Vanda Pharmaceuticals Inc [2017-06-19] 5.1
Great Point Partners LLC Vanda Pharmaceuticals Inc [2017-02-17] 5.04
Point72 Asset Management LP Vanda Pharmaceuticals Inc [2017-02-16] 5.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2016-01-27] 4.3
Great Point Partners LLC Vanda Pharmaceuticals Inc [2016-01-15] 5.45
Stonepine Capital Management LLC Vanda Pharmaceuticals Inc [2015-07-02] 5.5
Armistice Capital LLC Vanda Pharmaceuticals Inc [2015-03-27] 5.5
Paulson & Co Inc Vanda Pharmaceuticals Inc [2015-02-17] 0.14
Flynn James E Vanda Pharmaceuticals Inc [2014-08-01] 6.09
Price T Rowe Associates Inc /MD/ Vanda Pharmaceuticals Inc [2014-07-10] 10.1
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2014-02-14] 0.8
Kingdon Capital Management LLC Vanda Pharmaceuticals Inc [2014-02-14] 6.75
FMR LLC Vanda Pharmaceuticals Inc [2013-12-10] 0.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2013-10-11] 2.7
Baker Bros Advisors LLC Vanda Pharmaceuticals Inc [2013-06-10] 14.0
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2013-02-14] 5.1
First Eagle Investment Management LLC Vanda Pharmaceuticals Inc [2013-02-11] 6.77
[2012-12-10] None
Tang Capital Partners LP Vanda Pharmaceuticals Inc [2012-04-20] 6.9
Form 3/4/5 Filer 2011 - 2025
Vanda Pharmaceuticals Inc.
Polymeropoulos Mihael Hristos
Mitchell Stephen Ray
Dugan Richard W
Honore Tage
Ward Anne Sempowski
Chrousos Phaedra
Wijkstrom Joakim
Williams Timothy
Moran Kevin Patrick
Birznieks Gunther
Watkins Thomas
Jones Aranthan II
Reverberi Gian Piero
Kelly James Patrick
Cola Michael F
Milano Vincent
Gulino Richard L.
Bate Kenneth
Baroldi Paolo
Deerfield Mgmt L.P.
Flynn James E
Deerfield International Master Fund, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP
Deerfield Partners LP
Pien Howard H
Gibbs Thomas Edward
Deerfield Special Situations International Master Fund, L.P.
Galson Steven K
Repella Robert
Feeney John Joseph
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 8,511,442 9,435,626
Vanguard Group Inc [2025-06-30] SOLE 0 3,472,044
Renaissance Technologies LLC [2025-06-30] SOLE 3,447,460 3,447,460
Millennium Management LLC [2025-06-30] SOLE 3,120,339 3,120,339
Dimensional Fund Advisors LP [2025-06-30] SOLE 2,382,498 2,452,543
Tang Capital Management LLC [2025-06-30] OTR 0 2,353,307
Geode Capital Management LLC [2025-06-30] DFND 1,691,638 1,691,638
State Street Corp [2025-06-30] DFND 1,193,442 1,265,847
Krensavage Asset Management LLC [2025-06-30] SOLE 1,024,883 1,024,883
Morgan Stanley [2025-06-30] DFND 746,770 900,477
Caption Management LLC [2025-06-30] SOLE 884,486 884,486
Citigroup Inc [2025-06-30] DFND 880,603 880,603
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 868,419 868,419
Two Sigma Advisers LP [2025-06-30] SOLE 770,600 809,200
Federated Hermes Inc [2025-06-30] DFND 728,494 728,494
Prudential Financial Inc [2025-06-30] DFND 600,789 606,003
Two Sigma Investments LP [2025-06-30] SOLE 526,866 526,866
Marshall Wace LLP [2025-06-30] OTR 0 471,720
Northern Trust Corp [2025-06-30] DFND 449,862 450,211
Charles Schwab Investment Management Inc [2025-06-30] SOLE 450,207 450,207
Susquehanna International Group LLP [2025-06-30] OTR 177,251 411,151
Goldman Sachs Group Inc [2025-06-30] DFND 405,286 406,731
GSA Capital Partners LLP [2025-06-30] SOLE 382,071 382,071
Profit Investment Management LLC [2025-06-30] SOLE 329,822 329,822
Schroder Investment Management Group [2025-06-30] SOLE 307,176 307,176
Monaco Asset Management SAM [2025-06-30] SOLE 305,000 305,000
Wellington Management Group LLP [2025-06-30] DFND 0 292,495
Stonepine Capital Management LLC [2025-06-30] SOLE 250,000 250,000
Kennedy Capital Management LLC [2025-06-30] SOLE 237,468 237,468
Barclays PLC [2025-06-30] SOLE 224,404 224,404
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com